10/25/2013 3:37:41 PM
by Richard Daverman, PhD
October 25, 2013 -- Boston Scientific received CFDA approval for the Alair® Bronchial Thermoplasty System, a medical device that treats severe asthma when drugs do not control attacks. Using the Alair System, Bronchial Thermoplasty applies radiofrequency to produce mild heat that reduces excessive smooth muscle tissue in the airways. This lowers the constriction of airways during an attack and makes attacks both less frequent and less severe. More details....
Stock Symbol: (NYSE: BSX)
Help employers find you! Check out all the jobs and post your resume.
comments powered by